NET

ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31, 2024

Retrieved on: 
Montag, Mai 6, 2024
Charcot–Marie–Tooth disease, FDA, Venetoclax, OHSU, Innovation, National Cancer Institute, BPD, Development, IND, CNS, NET, Schizophrenia, EVOLUTION, JHU, Azacitidine, NCI, FCCC, Deficit spending, IP, Paclitaxel, IIS, Food, European Patent Convention, CMT, Borderline personality disorder, Communication, Conference, AML, Aggression, Convertible bond, FMS, ALS, Phase, Kabuki syndrome, HOPE, Safety, SCLC, DSM-IV codes, EMA, Clinical trial, Medicine, EPO, Investigational New Drug, Duration, Platinum, Bangladesh Technical Education Board, Phase II, MRD, ICIS, MSKCC, Disease, Measure (mathematics), CRADA, Dor, Patent, HDAC6, Data analysis, Genomics, Pharmaceutical industry

Dr Carlos Buesa, Oryzon’s Chief Executive Officer, said: “Oryzon continued with a strong path in its clinical programs in the first quarter.

Key Points: 
  • Dr Carlos Buesa, Oryzon’s Chief Executive Officer, said: “Oryzon continued with a strong path in its clinical programs in the first quarter.
  • Research and development (R&D) expenses were $2.6 million for the quarter ended March 31, 2024, compared to $4.4 million for the quarter ended March 31, 2023.
  • General and administrative expenses were $0.9 million for the quarter ended March 31, 2024, compared to $1.2 million for the quarter ended March 31, 2023.
  • Net losses were $1.1 for the quarter ended March 31, 2024, respectively, compared to $1.4 million for the quarter ended March 31, 2023.

Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update

Retrieved on: 
Dienstag, April 30, 2024
Oncology, Health, Research, Pharmaceutical, Science, Biotechnology, Education, PFS, Abbreviated New Drug Application, European Patent Office, Experiment, Breast, NET, ASCO, RCC, Associate, Translation, European Medicines Agency, Hearing, PIN, Drug development, European Patent Convention, Metastasis, Conference, Liver disease, ADC, Stada Arzneimittel, Tablet, Baylor College of Medicine, Distinguishing, Therapy, NHT, Calendar, BIRC, Huntsman Cancer Institute, OS, Dean (education), Docetaxel, PKMYT1, Checkmate, Prostate cancer, ITT, EPO, USP1, University, PARP, Immunotherapy, Superior, PLK4, Patent, Royalty payment, Patient, Society, Acquisition, Translational research, Neoplasm, Share repurchase, Annual general meeting, Baylor University

Exelixis’ 2024 net product revenues guidance range includes the impact of a U.S. wholesale acquisition cost increase of 2.2% for both CABOMETYX and COMETRIQ effective on January 1, 2024.

Key Points: 
  • Exelixis’ 2024 net product revenues guidance range includes the impact of a U.S. wholesale acquisition cost increase of 2.2% for both CABOMETYX and COMETRIQ effective on January 1, 2024.
  • Based upon cabozantinib-related net product revenues generated by Exelixis’ collaboration partners during the quarter ended March 31, 2024, Exelixis earned $39.6 million in royalty revenues.
  • In January, Exelixis announced the appointments of Mary C. Beckerle, Ph.D., and S. Gail Eckhardt, M.D., to the Exelixis Board of Directors, effective January 5, 2024.
  • Exelixis management will discuss the company’s financial results for the first quarter of 2024 and provide a general business update during a conference call beginning at 5:00 p.m.

Levi & Korsinsky, LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of PLDT Inc. American Depository Shares

Retrieved on: 
Mittwoch, April 10, 2024
LLP, Class Action, Claim, NET, District court, Tax, Lead, THIS, ALL, Motion, Hearing, American depositary receipt, ARE, READ, Person, Defendant, Federal building, Allocation, Prejudice, CLASS, Insurance

YOUR RIGHTS MAY BE AFFECTED BY THE PROPOSED SETTLEMENT OF A CLASS ACTION LAWSUIT PENDING IN THE UNITED STATES DISTRICT COURT FOR THE CENTRAL DISTRICT OF CALIFORNIA (THE “COURT”).

Key Points: 
  • YOUR RIGHTS MAY BE AFFECTED BY THE PROPOSED SETTLEMENT OF A CLASS ACTION LAWSUIT PENDING IN THE UNITED STATES DISTRICT COURT FOR THE CENTRAL DISTRICT OF CALIFORNIA (THE “COURT”).
  • ALL QUESTIONS ABOUT THIS NOTICE, THE PROPOSED SETTLEMENT, OR YOUR ELIGIBILITY TO PARTICIPATE IN THE PROPOSED SETTLEMENT SHOULD BE DIRECTED TO LEAD COUNSEL OR THE CLAIMS ADMINISTRATOR, WHOSE CONTACT INFORMATION IS PROVIDED BELOW.
  • You do NOT need to attend the Settlement Hearing in order to receive a distribution from the Net Settlement Fund.
  • IF YOU ARE A MEMBER OF THE CLASS, YOUR RIGHTS MAY BE AFFECTED BY THE PROPOSED SETTLEMENT AND YOU MAY BE ENTITLED TO SHARE IN THE NET SETTLEMENT FUND.

NET Power Schedules First Quarter 2024 Earnings Release and Conference Call

Retrieved on: 
Dienstag, April 23, 2024
Oil, Gas, Alternative Energy, Energy, Other Energy, Utilities, NET

NET Power Inc. (NYSE: NPWR) plans to report its first quarter 2024 financial results before market open on Monday, May 13, 2024, and will host a conference call to discuss the results beginning at 8:30 AM ET.

Key Points: 
  • NET Power Inc. (NYSE: NPWR) plans to report its first quarter 2024 financial results before market open on Monday, May 13, 2024, and will host a conference call to discuss the results beginning at 8:30 AM ET.
  • To access the live audio webcast of the conference call, please visit NET Power’s investor relations website at ir.netpower.com .
  • To participate by phone, dial 877-407-8014 (domestic) or +1 201-689-8053 (international).
  • An archived webcast will be available following the call.

BOW unveils first-of-its-kind robotics software with global OEMs at Hannover Messe

Retrieved on: 
Montag, April 22, 2024
Software, Technology, Robotics, Language, BOW, Mac, Bionics, JavaScript, Machine learning, SDK, OEM, Research, OS, Python, NET, Multimedia, Running, Linux, InMotion, 3D printing

BOW , the universal robotics software company that makes programming robots code-agnostic, interoperable and scalable, will today demonstrate real-world applications at the Hannover Messe exhibition with partners Sarcomere Dynamics and inMotion robotic, Hall 5/D46-3.

Key Points: 
  • BOW , the universal robotics software company that makes programming robots code-agnostic, interoperable and scalable, will today demonstrate real-world applications at the Hannover Messe exhibition with partners Sarcomere Dynamics and inMotion robotic, Hall 5/D46-3.
  • Hannover Messe (22-26 April) is one of the world’s largest and most important events for Industrial Transformation, attracting over 130,000 attendees.
  • BOW is the official software partner for Sarcomere Dynamics and inMotion robotic - together with its partner Deep Robotics - two leading robotics companies that will be demonstrating BOW-enabled applications on their stands at Hannover Messe.
  • inMotion robotic and its partner Deep Robotics are a global OEM pioneering the development and industrial application of bionic quadruped robots.

Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial

Retrieved on: 
Mittwoch, März 13, 2024
Dopamine, NET, Reward, Sheba Medical Center, CWY, Psychiatry, Serotonin, Patient, Research, MEAI, Alcoholism, Clinical trial, DAT, Safety, Norepinephrine, Yale school, Therapy, Ministry, Pharmaceutical industry

The approval, previously announced on February 23, 2024, allows Clearmind to start its pioneering clinical trial.

Key Points: 
  • The approval, previously announced on February 23, 2024, allows Clearmind to start its pioneering clinical trial.
  • The clinical trial is a multinational, multi-center, single and multiple dose tolerability, safety and pharmacokinetic study of CMND-100 in healthy volunteers and AUD subjects.
  • The Clearmind team has been working tirelessly on the research and development of a novel treatment to the global epidemic of alcoholism.
  • We are eager to continue our work with patients in need of help,” said Dr. Adi Zuloff-Shani, CEO of Clearmind Medicine.

NET Power Reports Fourth Quarter and Year End 2023 Results and Provides Business Update

Retrieved on: 
Montag, März 11, 2024
Environment, Other Energy, Environmental Health, Utilities, Oil, Gas, Alternative Energy, Sustainability, Green Technology, Energy, Permian, FEED, NET, Partnership, ASU, EPC, Occidental Petroleum, Investment, Engineering, Rare-earth element

NET Power Inc. (NYSE: NPWR) (“NET Power” or the “Company”) today reported results for the fourth quarter and year end 2023.

Key Points: 
  • NET Power Inc. (NYSE: NPWR) (“NET Power” or the “Company”) today reported results for the fourth quarter and year end 2023.
  • Danny Rice, Chief Executive Officer of NET Power, commented, “Our team concluded the fourth quarter of 2023 with steady progress across our three strategic pillars.
  • “2023 was a historic year for NET Power, which included completing our business combination with Rice Acquisition Corp. II and becoming a publicly listed company on the NYSE in June.
  • NET Power will host a conference call to discuss fourth quarter and year end 2023 financial results beginning at 8:30 AM ET on Tuesday, March 12.

MESCIUS inc. Launches ActiveReports .NET v18

Retrieved on: 
Donnerstag, März 28, 2024
NET, ActiveReports, UI

PITTSBURGH, March 28, 2024 /PRNewswire/ -- MESCIUS inc., a global provider of award-winning enterprise software development tools, is pleased to announce the release of ActiveReports.

Key Points: 
  • PITTSBURGH, March 28, 2024 /PRNewswire/ -- MESCIUS inc., a global provider of award-winning enterprise software development tools, is pleased to announce the release of ActiveReports.
  • ActiveReports.
  • Read the release announcement from ActiveReports .NET to learn more about the new theme support in v18.
  • With v18, ActiveReports.

VNET Reports Unaudited Fourth Quarter and Full Year 2023 Financial Results

Retrieved on: 
Mittwoch, März 27, 2024
Research, NET, PIN, Employment, The Company, CASH, Growth, H.10, RMB, LOSS, Acquisition, IDC, AI, ADS, Translation, Bank statement, Investment, Note, GAAP, Depreciation, VNET, Debt-to-GDP ratio, USD, Marketing, Video game

BEIJING, March 27, 2024 /PRNewswire/ -- VNET Group, Inc. (Nasdaq: VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral internet data center services provider in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2023.

Key Points: 
  • BEIJING, March 27, 2024 /PRNewswire/ -- VNET Group, Inc. (Nasdaq: VNET) ("VNET" or the "Company"), a leading carrier- and cloud-neutral internet data center services provider in China, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2023.
  • Qiyu Wang, Chief Financial Officer of VNET, commented, "We delivered robust 2023 results through our strategic focus on high-quality revenues.
  • Retail IDC MRR[2] per cabinet was RMB9,477 in the fourth quarter of 2023, compared with RMB9,495 in the third quarter of 2023 and RMB9,371 in the fourth quarter of 2022.
  • GROSS PROFIT: Gross profit in the fourth quarter of 2023 was RMB290.9 million (US$41.0 million), compared with RMB328.4 million in the same period of 2022.

Central Pattana, Thailand's No. 1 developer, aims to increase retail space in Bangkok by 2.2 million square meters, unveiling a 121 billion-Baht investment over the next five years

Retrieved on: 
Montag, März 25, 2024
NET, CRM, Ecosystem, Phra Pathommachedi, Growth, Intelligence, Partnership, The Cheesecake Factory, CentralPlaza Bangna, Shake Shack, Gateway, CentralWorld, Central Chaengwattana, PopMart Tour, Commercial, Quality of life, CPN, Marketing, CentralPlaza Pinklao, City, Behavior, Investment, Dusit Central Park, Residence, Central Pattana, Tourism, Central Rattanathibet, Heart, All, Dusit Thani Bangkok, BIZ

Last year, we achieved success in terms of annual performance with revenue of 46,790 million baht, a 26% increase from the previous year.

Key Points: 
  • Last year, we achieved success in terms of annual performance with revenue of 46,790 million baht, a 26% increase from the previous year.
  • Over the next 5 years, from 2024 to 2028, a total investment of 121,000 million baht is scheduled.
  • This year, we are undertaking a turnaround of shopping centers strategically located around the Bangkok Metropolitan Area: Central Pinklao, Central Bangna, Central Chaengwattana, Central Rattanathibet.
  • Central Pattana Public Company Limited (CPN), is striving towards the future under the brand purpose of "Imagining better futures for All."